Insider Selling: Varex Imaging Co. (NASDAQ:VREX) SVP Sells 4,007 Shares of Stock

Varex Imaging Co. (NASDAQ:VREX) SVP Kimberley E. Honeysett sold 4,007 shares of the stock in a transaction that occurred on Thursday, March 20th. The shares were sold at an average price of $12.81, for a total value of $51,329.67. Following the transaction, the senior vice president now directly owns 4,002 shares of the company’s stock, valued at $51,265.62. The trade was a 50.03 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Varex Imaging Stock Down 2.3 %

Shares of Varex Imaging stock traded down $0.29 during trading hours on Friday, hitting $12.57. 397,419 shares of the company’s stock traded hands, compared to its average volume of 526,012. Varex Imaging Co. has a twelve month low of $10.19 and a twelve month high of $18.30. The company has a market cap of $517.88 million, a PE ratio of -10.74 and a beta of 0.56. The company has a quick ratio of 2.50, a current ratio of 4.36 and a debt-to-equity ratio of 1.02. The stock has a 50 day simple moving average of $13.29 and a 200-day simple moving average of $13.41.

Varex Imaging (NASDAQ:VREX) last posted its quarterly earnings data on Thursday, February 6th. The company reported $0.07 EPS for the quarter, beating analysts’ consensus estimates of $0.04 by $0.03. Varex Imaging had a negative net margin of 5.79% and a positive return on equity of 4.00%. Equities research analysts anticipate that Varex Imaging Co. will post 0.53 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts recently issued reports on VREX shares. StockNews.com raised Varex Imaging from a “hold” rating to a “buy” rating in a research note on Friday, February 7th. B. Riley reaffirmed a “buy” rating and issued a $22.00 price objective (up previously from $21.00) on shares of Varex Imaging in a report on Friday, February 7th. Finally, Oppenheimer decreased their price objective on shares of Varex Imaging from $30.00 to $23.00 and set an “outperform” rating on the stock in a report on Friday, February 7th.

Institutional Trading of Varex Imaging

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Aquatic Capital Management LLC acquired a new position in shares of Varex Imaging during the fourth quarter valued at $25,000. Quest Partners LLC bought a new stake in Varex Imaging in the 3rd quarter valued at about $41,000. Quadrant Capital Group LLC boosted its stake in Varex Imaging by 115.4% during the 4th quarter. Quadrant Capital Group LLC now owns 2,837 shares of the company’s stock valued at $41,000 after purchasing an additional 1,520 shares during the period. Point72 Hong Kong Ltd bought a new position in Varex Imaging in the 4th quarter worth about $48,000. Finally, KLP Kapitalforvaltning AS acquired a new stake in shares of Varex Imaging in the fourth quarter valued at approximately $98,000.

About Varex Imaging

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.